San Clemente, CA – March 6, 2025 – Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary…
Read More
On November 5, 2024, the VIVA Foundation reported on presentations at the VIVA25 conference, including two-year results of the DEEPER OUS clinical trial for the Reflow Medical Spur® Peripheral Retrievable…
San Clemente, CA – July 1, 2024 – Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces the first patient enrollments in “A pilot study of…
San Clemente, CA – May 08, 2024 – Reflow Medical, Inc., a developer of innovative devices focused on cardiovascular disease, announces completion of enrollment in the DEEPER REVEAL clinical trial…
San Clemente, CA—Jan. 15, 2024 – Reflow Medical, Inc., a developer of innovative medical devices focused on cardiovascular disease, announces it has received CE (Conformité Européenne) Mark certification in the…
In this episode, host Dr. Sabeen Dhand interviews Dr. Jihad Mustapha, interventional cardiologist, about new technology for treating CLI, including CTOP classification, CTO crossing techniques, and reentry devices. Click Here…
Reflow Medical is taking steps to prevent the community spread of COVID-19 and to ensure the safety of our employees. We are adapting to the changing environment as we continue…
Dr. Mathews, Director of the Cardiac Catheterization Laboratory at Manatee Memorial Hospital in Bradenton, Florida, joined Reflow Medical, Inc. at the conclusion of the Transcatheter Cardiovascular Therapeutics (TCT) symposium held…
View the Reflow video featured at the Hilton Chicago this week during AMP 2018.
Recent Comments